MannKind | MNKD - PE Price to Earnings


MannKind reported $30.56 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Adma Biologics USD 17.25 4.43 Sep/2025
Dynavax Technologies USD 13.52 34.14 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Halozyme Therapeutics USD 15.46 3.56 Sep/2025
MannKind USD 30.56 6.84 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Novo Nordisk DKK 13.92 4.91 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Sanofi EUR 11.99 1.58 Dec/2025
Xencor USD 29.92 3.22 Sep/2022